Back

Inhibition of adamts13: a novel therapy to treat mechanical circulatory support-induced acquired von willebrand syndrome

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction Drugs, Drug Targets ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Shannen Deconinck

Laboratory for Thrombosis Research, Kortrijk (Belgium)

6 More presentations in this session

Presentation thumbnail
A novel whole blood coagulometer for NOAC testing
Doctor S. Bakhru (Danbury, US)
Abstract Slides
Presentation thumbnail
Heparin is more effective than apixaban in inhibiting in vitro contact activated coagulation
Doctor M. Engelen (Leuven, BE)
Abstract Slides
Presentation thumbnail
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
Doctor M. Riederer (Allschwil, CH)
Abstract Slides
Presentation thumbnail
Shear stress induced activation of von Willebrand factor may predispose to gastrointestinal bleeding in syndrome of Heyde
Mrs Y. Avtaeva (Moscow, RU)
Abstract Slides
Presentation thumbnail
Aquaporin-1: a major modulator of aging-mediated platelet/endothelial dysfunction in atherothrombosis
Doctor S. Saeedi (Schlieren, CH)
Abstract Slides

Access the full session

Session thumbnail
Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction

The Event

Event poster

ESC Congress 2020

1 September 2020 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources